Oricula Therapeutics

0 followers


Oricula Therapeutics is working to develop the first medication to be approved to prevent drug-induced hearing loss.

Industries

Headquarters

Stage

Employees

Links

Org chart

Vince Groppi

Collapse
Graham Johnson
NuPharmAdvise, President
Marc Bailie
Chief Development Officer, INDS
David W. Raible
University of Washington, Professor
Henry Ou
University of Washington, Assoc Professor
Edwin W. Rubel
University of Washington, Chaired Professor